Results 231 to 240 of about 177,862 (267)

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri   +20 more
wiley   +1 more source

Optogenetic-induced α-synuclein accumulation reveals early synaptic dysfunction in experimental models of Parkinson's disease. [PDF]

open access: yesNPJ Parkinsons Dis
Rodriguez-Aller R   +6 more
europepmc   +1 more source

Dopaminergic receptor type 1 and DARPP-32 expressions during estrous cycle of the rat: evidence of a dopaminergic rhythm related to oxidative stress in the ovaries

open access: diamond
José Luis Morán-Perales   +3 more
openalex   +1 more source

Another Microlesion Effect after STN‐DBS for Parkinson's Disease

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Atsushi Umemura   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy